Physician profile
Scott M Panzer
NPI 1922002369
$1,162.61
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $964 · 2021: $43.74 · 2023: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $313.71 | 2019 | |
| Merz North America, INC. | $154.50 | 2023 | |
| Novartis Pharmaceuticals Corporation | $153.27 | 2019 | |
| Abbvie INC. | $93.14 | 2019 | |
| Genzyme Corporation | $82.79 | 2019 | |
| Janssen Biotech, INC. | $82.50 | 2019 | |
| Pfizer INC. | $74.89 | 2019 | |
| Sientra, INC. | $43.74 | 2021 | |
| Ucb, INC. | $41.69 | 2019 | |
| Sun Pharmaceutical Industries INC. | $24.69 | 2019 | |
| Celgene Corporation | $24.42 | 2019 | |
| Biofrontera INC. | $19.87 | 2019 | |
| Dusa Pharmaceuticals, INC. | $16.44 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.26 | 2019 | |
| Galderma Laboratories, L.P. | $11.42 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $11.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Panzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.